Cargando…
Novel Simulation Model of Non-Muscle Invasive Bladder Cancer: A Platform for a Virtual Randomized Trial of Conservative Therapy vs. Cystectomy in BCG Refractory Patients
Introduction: There have been no randomized controlled trials (RCTs) evaluating the clinical or economic benefit of mitomycin C intravesical therapy vs. radical cystectomy in patients with high-risk non-muscle invasive bladder cancer (NMIBC). We used the Archimedes computational model to simulate RC...
Autores principales: | Patel, Sanjay, Dinh, Tuan, Noah-Vanhoucke, Joyce, Rengarajan, Badri, Mayo, Kevin, Clark, Peter E., Kamat, Ashish M., Lee, Cheryl T., Sexton, Wade J., Steinberg, Gary D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927810/ https://www.ncbi.nlm.nih.gov/pubmed/27376114 http://dx.doi.org/10.3233/BLC-150020 |
Ejemplares similares
-
Optimal timing of chemotherapy and cystectomy
por: Karam, Jose A, et al.
Publicado: (2010) -
Once BCG Unresponsive, Always BCG Unresponsive: An Open Letter to the FDA to Enhance Recruitment into Clinical Trials in Bladder Cancer
por: Kamat, Ashish M., et al.
Publicado: (2017) -
Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer
por: Agarwal, Piyus K., et al.
Publicado: (2008) -
Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
por: Jinesh G., Goodwin, et al.
Publicado: (2012) -
Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy
por: Rao, Manoj V., et al.
Publicado: (2013)